Acquired Myasthenia Gravis
Immunology·MeSH: Myasthenia Gravis
Prevalence
20.0 / 100K
Incidence
1.7 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Acquired Myasthenia Gravis?
There are 1 clinical trial targeting Acquired Myasthenia Gravis tracked by BioSniper.
What is the prevalence of Acquired Myasthenia Gravis?
The estimated prevalence of Acquired Myasthenia Gravis is approximately 20.0 per 100,000 population.
Deep-dive into Acquired Myasthenia Gravis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis